Device and drug manufacturer
Issues relating to prescription drug shortages: --P.L. 111-148: Patient Protection and Affordable Health Care Act provisions relating to biosimilar products.; --H.R. 1919: Safeguarding America's Pharmaceuticals Act of 2013; --H.R. 3204: The Drug Quality and Safety Act; --S. 957: The Drug Supply Chain Security Act; --S. 232: Medical Device Access and Innovation Protection Act -- Issues relating to generic drug labeling
-- S. 959:  The Pharmaceutical Quality, Security and Accountability Act
-- H.R. 3204: The Compounding Clarity Act -- S. 1413: FDA User Fee Protection Act 
-- H.R. 2725: "FDA Safety Over Sequestration Act of 2013
HCR - Health Issues PHA - Pharmacy BUD - Budget/Appropriations
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office
BROWN RUDNICK LLP
601 13th Street, NW, 6th Floor, Washington, DC, 20005, US
HENRY W MENN (Min SD & Counsel, Cmte on Vet Affairs (04)) LISA LAYMAN (SPA, Sen Stabenow(05-07)) CHRISTOPHER BOWLIN (Secr for Congr & Intgv Affairs, Dept. Labor 01-02) HENRY W MENN CHRISTOPHER BOWLIN HENRY W MENN CHRISTOPHER BOWLIN
Min SD & Counsel, Cmte on Vet Affairs (04) SPA, Sen Stabenow(05-07) Secr for Congr & Intgv Affairs, Dept. Labor 01-02